Patents by Inventor Millard G. Cull

Millard G. Cull has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thermophilic polymerase III holoenzyme
    Patent number: 6238905
    Abstract: The present invention relates to gene and amino acid sequences encoding DNA polymerase III holoenzyme subunits and structural genes from thermophilic organisms. In particular, the present invention provides DNA polymerase III holoenzyme subunits of T. thermophilus. The present invention also provides antibodies and other reagents useful to identify DNA polymerase III molecules.
    Type: Grant
    Filed: September 12, 1997
    Date of Patent: May 29, 2001
    Assignee: University Technology Corporation
    Inventors: Charles S. McHenry, Mark Seville, Millard G. Cull
  • Peptide library and screening method
    Patent number: 6156511
    Abstract: A random peptide library constructed by transforming host cells with a collection of recombinant vectors that encode a fusion protein comprised of a DNA binding protein and a random peptide and also encode a binding site for the DNA. binding protein can be used to screen for novel ligands. The screening method results in the formation of a complex comprising the fusion protein bound to a receptor through the random peptide ligand and to the recombinant DNA vector through the DNA binding protein.
    Type: Grant
    Filed: January 21, 1998
    Date of Patent: December 5, 2000
    Assignee: Affymax Technologies N.V.
    Inventors: Peter J. Schatz, Millard G. Cull, Jeff F. Miller, Willem Peter Christiaan Stemmer, Christian M. Gates
  • Peptide library and screening method
    Patent number: 5733731
    Abstract: A random peptide library constructed by transforming host cells with a collection of recombinant vectors that encode a fusion protein comprised of a DNA binding protein and a random peptide and also encode a binding site for the DNA binding protein can be used to screen for novel ligands. The screening method results in the formation of a complex comprising the fusion protein bound to a receptor through the random peptide ligand and to the recombinant DNA vector through the DNA binding protein.
    Type: Grant
    Filed: October 26, 1995
    Date of Patent: March 31, 1998
    Assignee: Affymax Technologies N.V.
    Inventors: Peter J. Schatz, Millard G. Cull, Jeff F. Miller, Willem Peter Christiaan Stemmer, Christian M. Gates
  • Peptide library and screening method
    Patent number: 5498530
    Abstract: A random peptide library constructed by transforming host cells with a collection of recombinant vectors that encode a fusion protein comprised of a DNA binding protein and a random peptide and also contain a binding site for the DNA binding protein can be used to screen for novel ligands. The screening method results in the formation of a complex comprising the fusion protein bound to a receptor through the random peptide ligand and to the recombinant DNA vector through the DNA binding protein.
    Type: Grant
    Filed: August 15, 1994
    Date of Patent: March 12, 1996
    Assignee: Affymax Technologies, N.V.
    Inventors: Peter J. Schatz, Millard G. Cull, Jeff F. Miller, Willem P. C. Stemmer
  • Peptide library and screening method
    Patent number: 5270170
    Abstract: A random peptide library constructed by transforming host cells with a collection of recombinant vectors that encode a fusion protein comprised of a DNA binding protein and a random peptide and also encode a binding site for the DNA binding protein can be used to screen for novel ligands. The screening method results in the formation of a complex comprising the fusion protein bound to a receptor through the random peptide ligand and to the recombinant DNA vector through the DNA binding protein.
    Type: Grant
    Filed: October 16, 1991
    Date of Patent: December 14, 1993
    Assignee: Affymax Technologies N.V.
    Inventors: Peter J. Schatz, Millard G. Cull, Jeff F. Miller